Varubi Prices, Coupons and Patient Assistance Programs
Varubi (rolapitant) is a member of the NK1 receptor antagonists drug class and is commonly used for Nausea/Vomiting - Chemotherapy Induced.
Varubi Prices
This Varubi price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Varubi intravenous emulsion (166.5 mg/92.5 mL) is around $316 for a supply of 92.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Varubi is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Varubi availability.
Intravenous Emulsion
| Quantity | Per unit | Price |
|---|---|---|
| 92.5 milliliters | $3.42 | $316.48 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Oral Tablet
| Quantity | Per unit | Price |
|---|---|---|
| 2 | $315.10 | $630.20 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Varubi Coupons and Rebates
Varubi offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Varubi Commercial Co-pay Assistance Program: Eligible patients may have $0 co-pay with a $300 per dose cap and no annual maximum; for additional information contact your healthcare provider or the program at 844-283-7276.
| Applies to: | Varubi |
| Number of uses: | Per prescription until program expires |
Varubi First Dose Program: Eligible patients may be able to receive a single dose (oral medication) at no cost; for additional information contact the program at 844-283-7276.
| Applies to: | Varubi |
| Number of uses: | One-time offer |
Patient Assistance Programs for Varubi
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- Medically appropriate condition/diagnosis
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Varubi (rolapitant)
Provider: Together with Tesaro Patient Assistance Program
Elligibility requirements:
- Determined case by case
- Not disclosed
- Medically appropriate condition/diagnosis
- US residency requirements are not specified.
- This program also provides copay assistance and they will provide a Free First Dose of VARUBI (rolapitant), if there is a delay in coverage determination. Contact the program for more detail.
Applicable drugs:
- Varubi (rolapitant)
More about Varubi (rolapitant)
- Varubi Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 1 Review
- Drug class: NK1 receptor antagonists
Consumer resources
- Varubi
- Varubi (Rolapitant Injection)
- Varubi (Rolapitant Tablets)
- Varubi (Advanced Reading)
- Varubi Intravenous (Advanced Reading)
